BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 29921889)

  • 1. Positron emission tomography of type 2 cannabinoid receptors for detecting inflammation in the central nervous system.
    Ni R; Mu L; Ametamey S
    Acta Pharmacol Sin; 2019 Mar; 40(3):351-357. PubMed ID: 29921889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased in vivo availability of the cannabinoid type 2 receptor in Alzheimer's disease.
    Ahmad R; Postnov A; Bormans G; Versijpt J; Vandenbulcke M; Van Laere K
    Eur J Nucl Med Mol Imaging; 2016 Nov; 43(12):2219-2227. PubMed ID: 27488857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Upregulation of cannabinoid receptor type 2, but not TSPO, in senescence-accelerated neuroinflammation in mice: a positron emission tomography study.
    Yamagishi S; Iga Y; Nakamura M; Takizawa C; Fukumoto D; Kakiuchi T; Nishiyama S; Ohba H; Tsukada H; Sato K; Ouchi Y
    J Neuroinflammation; 2019 Nov; 16(1):208. PubMed ID: 31707986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PET imaging of cannabinoid type 2 receptors with [
    Pottier G; Gómez-Vallejo V; Padro D; Boisgard R; Dollé F; Llop J; Winkeler A; Martín A
    J Cereb Blood Flow Metab; 2017 Mar; 37(3):1163-1178. PubMed ID: 28079433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radioligands for positron emission tomography imaging of cannabinoid type 2 receptor.
    Spinelli F; Mu L; Ametamey SM
    J Labelled Comp Radiopharm; 2018 Mar; 61(3):299-308. PubMed ID: 29110331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CB2 Receptor in Microglia: The Guardian of Self-Control.
    Komorowska-Müller JA; Schmöle AC
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33375006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. From Structure-Activity Relationships on Thiazole Derivatives to the In Vivo Evaluation of a New Radiotracer for Cannabinoid Subtype 2 PET Imaging.
    Caillé F; Cacheux F; Peyronneau MA; Jego B; Jaumain E; Pottier G; Ullmer C; Grether U; Winkeler A; Dollé F; Damont A; Kuhnast B
    Mol Pharm; 2017 Nov; 14(11):4064-4078. PubMed ID: 28968497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cannabinoid type 2 receptor activation downregulates stroke-induced classic and alternative brain macrophage/microglial activation concomitant to neuroprotection.
    Zarruk JG; Fernández-López D; García-Yébenes I; García-Gutiérrez MS; Vivancos J; Nombela F; Torres M; Burguete MC; Manzanares J; Lizasoain I; Moro MA
    Stroke; 2012 Jan; 43(1):211-9. PubMed ID: 22020035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis, Structure-Activity Relationships, Radiofluorination, and Biological Evaluation of [
    Teodoro R; Gündel D; Deuther-Conrad W; Kazimir A; Toussaint M; Wenzel B; Bormans G; Hey-Hawkins E; Kopka K; Brust P; Moldovan RP
    J Med Chem; 2023 Oct; 66(20):13991-14010. PubMed ID: 37816245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cannabinoid Receptor 2 Alters Social Memory and Microglial Activity in an Age-Dependent Manner.
    Komorowska-Müller JA; Rana T; Olabiyi BF; Zimmer A; Schmöle AC
    Molecules; 2021 Oct; 26(19):. PubMed ID: 34641528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-Activity Relationship Studies of Pyridine-Based Ligands and Identification of a Fluorinated Derivative for Positron Emission Tomography Imaging of Cannabinoid Type 2 Receptors.
    Haider A; Kretz J; Gobbi L; Ahmed H; Atz K; Bürkler M; Bartelmus C; Fingerle J; Guba W; Ullmer C; Honer M; Knuesel I; Weber M; Brink A; Herde AM; Keller C; Schibli R; Mu L; Grether U; Ametamey SM
    J Med Chem; 2019 Dec; 62(24):11165-11181. PubMed ID: 31751140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular and functional interaction between GPR18 and cannabinoid CB
    Reyes-Resina I; Navarro G; Aguinaga D; Canela EI; Schoeder CT; Załuski M; Kieć-Kononowicz K; Saura CA; Müller CE; Franco R
    Biochem Pharmacol; 2018 Nov; 157():169-179. PubMed ID: 29870711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cannabinoid CB
    López A; Aparicio N; Pazos MR; Grande MT; Barreda-Manso MA; Benito-Cuesta I; Vázquez C; Amores M; Ruiz-Pérez G; García-García E; Beatka M; Tolón RM; Dittel BN; Hillard CJ; Romero J
    J Neuroinflammation; 2018 May; 15(1):158. PubMed ID: 29793509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of cannabinoid type 2 receptors (CB2Rs) in neuroprotection against neurological disorders.
    Xin Q; Xu F; Taylor DH; Zhao JF; Wu J
    Acta Pharmacol Sin; 2020 Dec; 41(12):1507-1518. PubMed ID: 33024239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of [
    Teodoro R; Gündel D; Deuther-Conrad W; Ueberham L; Toussaint M; Bormans G; Brust P; Moldovan RP
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stimulation of brain glucose uptake by cannabinoid CB2 receptors and its therapeutic potential in Alzheimer's disease.
    Köfalvi A; Lemos C; Martín-Moreno AM; Pinheiro BS; García-García L; Pozo MA; Valério-Fernandes Â; Beleza RO; Agostinho P; Rodrigues RJ; Pasquaré SJ; Cunha RA; de Ceballos ML
    Neuropharmacology; 2016 Nov; 110(Pt A):519-529. PubMed ID: 26976670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CB2 receptor in the CNS: From immune and neuronal modulation to behavior.
    Grabon W; Rheims S; Smith J; Bodennec J; Belmeguenai A; Bezin L
    Neurosci Biobehav Rev; 2023 Jul; 150():105226. PubMed ID: 37164044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo TSPO and cannabinoid receptor type 2 availability early in post-stroke neuroinflammation in rats: a positron emission tomography study.
    Hosoya T; Fukumoto D; Kakiuchi T; Nishiyama S; Yamamoto S; Ohba H; Tsukada H; Ueki T; Sato K; Ouchi Y
    J Neuroinflammation; 2017 Mar; 14(1):69. PubMed ID: 28356120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cannabinoid 2 receptor is a novel anti-inflammatory target in experimental proliferative vitreoretinopathy.
    Szczesniak AM; Porter RF; Toguri JT; Borowska-Fielding J; Gebremeskel S; Siwakoti A; Johnston B; Lehmann C; Kelly ME
    Neuropharmacology; 2017 Feb; 113(Pt B):627-638. PubMed ID: 27569993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-Based Design, Optimization, and Development of [
    Gündel D; Deuther-Conrad W; Ueberham L; Kaur S; Otikova E; Teodoro R; Toussaint M; Lai TH; Clauß O; Scheunemann M; Bormans G; Bachmann M; Kopka K; Brust P; Moldovan RP
    J Med Chem; 2022 Jul; 65(13):9034-9049. PubMed ID: 35771668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.